AAAAAA

   
Results: 1-13 |
Results: 13
INTERNATIONAL EVALUATION OF ZONISAMIDE EFFICACY
Authors: LEPPIK I SEINO M YAGI K WILDER B
Citation: I. Leppik et al., INTERNATIONAL EVALUATION OF ZONISAMIDE EFFICACY, Neurology, 50(4), 1998, pp. 2051-2051
SUBJECTIVE EFFICACY OF ZOLPIDEM IN OUTPATIENTS WITH CHRONIC INSOMNIA - A DOUBLE-BLIND COMPARISON WITH PLACEBO
Authors: LAHMEYER H WILCOX CS KANN J LEPPIK I
Citation: H. Lahmeyer et al., SUBJECTIVE EFFICACY OF ZOLPIDEM IN OUTPATIENTS WITH CHRONIC INSOMNIA - A DOUBLE-BLIND COMPARISON WITH PLACEBO, Clinical drug investigation, 13(3), 1997, pp. 134-144
FACTORS AFFECTING ANTICONVULSANT DRUG COMPLIANCE IN EPILEPSY IN AN HMO POPULATION
Authors: WIELINSKI CL FRIEDMAN F FU QG LEPPIK I WOLFF D
Citation: Cl. Wielinski et al., FACTORS AFFECTING ANTICONVULSANT DRUG COMPLIANCE IN EPILEPSY IN AN HMO POPULATION, Neurology, 48(3), 1997, pp. 3054-3054
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VIGABATRIN 3 G DAY IN PATIENTS WITH UNCONTROLLED COMPLEX PARTIAL SEIZURES/
Authors: FRENCH JA MOSIER M WALKER S SOMMERVILLE K SUSSMAN N BARRY E BELL W BERGEN D BROWNE T FERRENDELLI J FISHER R FROMM G HOMAN R KRAUSS G LAI CW LEPPIK I LEROY R PELLOCK J PENOVICH P RAMSAY RE SHINNAR S
Citation: Ja. French et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VIGABATRIN 3 G DAY IN PATIENTS WITH UNCONTROLLED COMPLEX PARTIAL SEIZURES/, Neurology, 46(1), 1996, pp. 54-61
SAFETY OF INTRAVENOUS VALPROATE
Authors: DEVINSKY O LEPPIK I WILMORE LJ PELLOCK JM DEAN C GATES J RAMSAY RE ABOUKHALIL B AHMANN P BARKLEY G BOGDANOFF B BROWN L CAHILL W DRISLANE F EATON J EHLE A FAUGHT RE GALLAGHER B GATES J HOMAN R IYER V JACOBS A KELLY J LABINER D LEPPIK I LEVISOHN P LICHT JM MANDELBAUM M MATSUO F MATTSON RH MIRZA W MORRELL MJ NARITOKU D NAZARIAN S OJEMANN L PELLOCK JM PENRY K PHILLIPS C RAK I RAMANI V RAMSAY E REMLER B RODICHOK L ROWAN AJ SALINSKY M SCHEYER RD VALERIANO J WATSON C WILLMORE LJ YERBY M YOUNG B ZACHARIAH S
Citation: O. Devinsky et al., SAFETY OF INTRAVENOUS VALPROATE, Annals of neurology, 38(4), 1995, pp. 670-674
SAFETY AND EFFICACY OF BID AND QID DOSING WITH TIAGABINE HCL VERSUS PLACEBO AS ADJUNCTIVE TREATMENT FOR PARTIAL SEIZURES
Authors: SACHDEO R LEROY R KRAUSS G GREEN P DRAKE M LEPPIK I SHU V RINGHAM G SOMMERVILLE K
Citation: R. Sachdeo et al., SAFETY AND EFFICACY OF BID AND QID DOSING WITH TIAGABINE HCL VERSUS PLACEBO AS ADJUNCTIVE TREATMENT FOR PARTIAL SEIZURES, Neurology, 45(4), 1995, pp. 202-202
A PHARMACOKINETIC STUDY OF TIAGABINE HCL IN PATIENTS AT VARIOUS STEADY-STATE DOSES
Authors: WOLFF D LEPPIK I SO E GUSTAVSON L PIXTON G KAPLY C RINGHAM G SOMMERVILLE K
Citation: D. Wolff et al., A PHARMACOKINETIC STUDY OF TIAGABINE HCL IN PATIENTS AT VARIOUS STEADY-STATE DOSES, Neurology, 45(4), 1995, pp. 249-249
PROSPECTIVE-STUDY OF DEATH IN EPILEPSY - AN UPDATE
Authors: AHMANN P SO E LEPPIK I RARICK J HAUSER WA
Citation: P. Ahmann et al., PROSPECTIVE-STUDY OF DEATH IN EPILEPSY - AN UPDATE, Epilepsia, 36, 1995, pp. 6-6
THE LONG-TERM SAFETY AND EFFICACY OF GABAPENTIN (NEURONTIN(R)) AS ADD-ON THERAPY IN DRUG-RESISTANT PARTIAL EPILEPSY
Authors: OOMMEN K PENRY J RIELA A ROWAN A ROSENBAUM D SCHEAR M SIVAK M WIENER J SAUERMANN W WIBBERG M SMITH D KRAMER R YERBY M LESSER R FISHER R SANDERS P NORTH R HOMAN R HAYES A SHELLENBERGER MK TRUDEAU V WALLACE J SACKELLARES J AASVED K HIRSCHORN K OLSON L LEPPIK I RASK C ROSENFELD W FROMM GH NAGEL N DREIFUSS F BERTRAM E COOPER G LEE SI OJEMANN L WILENSKY A ABOUKHALIL B COURVILLE K MCLEAN M RAMSAY R GUTERMAN A MCJILTON J SANCHEZ R SLATER J MATTSON R SCHEYER R TREIMAN D HANDFORTH A
Citation: K. Oommen et al., THE LONG-TERM SAFETY AND EFFICACY OF GABAPENTIN (NEURONTIN(R)) AS ADD-ON THERAPY IN DRUG-RESISTANT PARTIAL EPILEPSY, Epilepsy research, 18(1), 1994, pp. 67-73
STRESSFUL LIFE EVENTS AND SEIZURE FREQUENCY IN PATIENTS WITH EPILEPSY
Authors: NEUGEBAUER R PAIK M HAUSER WA NADEL E LEPPIK I SUSSER M
Citation: R. Neugebauer et al., STRESSFUL LIFE EVENTS AND SEIZURE FREQUENCY IN PATIENTS WITH EPILEPSY, Epilepsia, 35(2), 1994, pp. 336-343
GUIDELINES FOR ANTIEPILEPTIC DRUG TRIALS IN CHILDREN
Authors: GRAM L DULAC O FREY HH GONZALESASTIAZARAN A LEPPIK I LOISEAU P PERRET A
Citation: L. Gram et al., GUIDELINES FOR ANTIEPILEPTIC DRUG TRIALS IN CHILDREN, Epilepsia, 35(1), 1994, pp. 94-100
PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF LAMOTRIGINE INPATIENTS WITH PARTIAL SEIZURES
Authors: MATSUO F BERGEN D FAUGHT E MESSENHEIMER JA DREN AT RUDD GD LINEBERRY CG MADSEN JA RISTANOVIC R ERENBERG G KRAMER RE HARNER RN SCHOMER DL LEPPIK I COLLINS SD KING KW SHAMSNIA M WHITE RL GAY PE ROTHNER AD DRAKE ME DETOLEDO J SUSSMAN NM MIKATI MA OLSON D FROMM G MURRO AM EHLE A FOLEY JF MORRIS HH SMITH DB SO EL SCHACHTER SC KUZNIECKY R LAXER K GALLAGHER BB WEISBERG LA MOORE EL
Citation: F. Matsuo et al., PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF LAMOTRIGINE INPATIENTS WITH PARTIAL SEIZURES, Neurology, 43(11), 1993, pp. 2284-2291
GABAPENTIN AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY
Authors: OOMMEN K PENRY J RIELA A ROWAN AJ ROSENBAUM D SCHEAR M SIVAK M WIENER J SAUERMANN W WIBBERG M SMITH D KRAMER R YERBY M LESSER R FISHER R SANDERS P NORTH R HOMAN R ALEXANDER J SHELLENBERGER MK WALLACE J SACKELLARES J AASVED K HIRSCHORN K OLSON L LEPPIK I RASK C ROSENFELD W FROMM GH NAGEL N DREIFUSS F BERTRAM E COOPER G LEE SI OJEMANN L WILENSKY A ABOUKHALIL B COURVILLE K MCLEAN M RAMSAY RE GUTERMAN A MCJILTON J SANCHEZ R SLATER J MATTSON R SCHEYER R TREIMAN D HANDFORTH A
Citation: K. Oommen et al., GABAPENTIN AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY, Neurology, 43(11), 1993, pp. 2292-2298
Risultati: 1-13 |